Covid-19 Impact on Medical Cannabis Market, Global Research Reports 2020-2021

This report covers market size and forecasts of Medical Cannabis, including the following market information:

    Global Medical Cannabis Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (MT)

    Global Medical Cannabis Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (MT)

Key market players

Major competitors identified in this market include BOL Pharma, Tilray, Medreleaf Corporation, Aurora Cannabis, Inc, Canopy Growth Corporation, Insys Therapeutics, Inc, Aphria, Inc, MGC Pharmaceuticals Limited, GW Pharmaceuticals, plc, Medical Marijuana Inc, etc.

Based on the Region:

    Asia-Pacific (China, Japan, South Korea, India and ASEAN)

    North America (US and Canada)

    Europe (Germany, France, UK and Italy)

    Rest of World (Latin America, Middle East & Africa)

Based on the Type:

    Tetrahydrocannabinol (THC)

    Cannabidiol (CBD)

Based on the Application:

    Pain

    Arthritis

    Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)

    Others

1.1 Research Scope

1.2 Market Segmentation

1.3 Research Objectives

1.4 Research Methodology

1.4.1 Research Process

1.4.2 Data Triangulation

1.4.3 Research Approach

1.4.4 Base Year

1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth

1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections

1.5.2 Covid-19 Impact: Commodity Prices Indices

1.5.3 Covid-19 Impact: Global Major Government Policy

1.6 The Covid-19 Impact on Medical Cannabis Industry

1.7 COVID-19 Impact: Medical Cannabis Market Trends

2.1 Medical Cannabis Business Impact Assessment - COVID-19

2.1.1 Global Medical Cannabis Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.1.2 Global Medical Cannabis Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026

2.2 Global Medical Cannabis Quarterly Market Size 2020-2021

2.3 COVID-19-Driven Market Dynamics and Factor Analysis

2.3.1 Drivers

2.3.2 Restraints

2.3.3 Opportunities

2.3.4 Challenges

3.1 Global Medical Cannabis Quarterly Market Size by Manufacturers, 2019 VS 2020

3.2 Global Medical Cannabis Factory Price by Manufacturers

3.3 Location of Key Manufacturers Medical Cannabis Manufacturing Factories and Area Served

3.4 Date of Key Manufacturers Enter into Medical Cannabis Market

3.5 Key Manufacturers Medical Cannabis Product Offered

3.6 Mergers & Acquisitions, Expansion Plans

4.1 Introduction

1.4.1 Tetrahydrocannabinol (THC)

1.4.2 Cannabidiol (CBD)

4.2 By Type, Global Medical Cannabis Market Size, 2019-2021

4.2.1 By Type, Global Medical Cannabis Market Size by Type, 2020-2021

4.2.2 By Type, Global Medical Cannabis Price, 2020-2021

5.1 Overview

5.5.1 Pain

5.5.2 Arthritis

5.5.3 Neurological Disease (Epilepsy, Multiple Sclerosis and Other Neurological Applications)

5.5.4 Others

5.2 By Application, Global Medical Cannabis Market Size, 2019-2021

5.2.1 By Application, Global Medical Cannabis Market Size by Application, 2019-2021

5.2.2 By Application, Global Medical Cannabis Price, 2020-2021

6.1 Introduction

6.2 North America

6.2.1 Macroeconomic Indicators of US

6.2.2 US

6.2.3 Canada

6.3 Europe

6.3.1 Macroeconomic Indicators of Europe

6.3.2 Germany

6.3.3 France

6.3.4 UK

6.3.5 Italy

6.4 Asia-Pacific

6.4.1 Macroeconomic Indicators of Asia-Pacific

6.4.2 China

6.4.3 Japan

6.4.4 South Korea

6.4.5 India

6.4.6 ASEAN

6.5 Rest of World

6.5.1 Latin America

6.5.2 Middle East and Africa

7.1 BOL Pharma

7.1.1 BOL Pharma Business Overview

7.1.2 BOL Pharma Medical Cannabis Quarterly Production and Revenue, 2020

7.1.3 BOL Pharma Medical Cannabis Product Introduction

7.1.4 BOL Pharma Response to COVID-19 and Related Developments

7.2 Tilray

7.2.1 Tilray Business Overview

7.2.2 Tilray Medical Cannabis Quarterly Production and Revenue, 2020

7.2.3 Tilray Medical Cannabis Product Introduction

7.2.4 Tilray Response to COVID-19 and Related Developments

7.3 Medreleaf Corporation

7.3.1 Medreleaf Corporation Business Overview

7.3.2 Medreleaf Corporation Medical Cannabis Quarterly Production and Revenue, 2020

7.3.3 Medreleaf Corporation Medical Cannabis Product Introduction

7.3.4 Medreleaf Corporation Response to COVID-19 and Related Developments

7.4 Aurora Cannabis, Inc

7.4.1 Aurora Cannabis, Inc Business Overview

7.4.2 Aurora Cannabis, Inc Medical Cannabis Quarterly Production and Revenue, 2020

7.4.3 Aurora Cannabis, Inc Medical Cannabis Product Introduction

7.4.4 Aurora Cannabis, Inc Response to COVID-19 and Related Developments

7.5 Canopy Growth Corporation

7.5.1 Canopy Growth Corporation Business Overview

7.5.2 Canopy Growth Corporation Medical Cannabis Quarterly Production and Revenue, 2020

7.5.3 Canopy Growth Corporation Medical Cannabis Product Introduction

7.5.4 Canopy Growth Corporation Response to COVID-19 and Related Developments

7.6 Insys Therapeutics, Inc

7.6.1 Insys Therapeutics, Inc Business Overview

7.6.2 Insys Therapeutics, Inc Medical Cannabis Quarterly Production and Revenue, 2020

7.6.3 Insys Therapeutics, Inc Medical Cannabis Product Introduction

7.6.4 Insys Therapeutics, Inc Response to COVID-19 and Related Developments

7.7 Aphria, Inc

7.7.1 Aphria, Inc Business Overview

7.7.2 Aphria, Inc Medical Cannabis Quarterly Production and Revenue, 2020

7.7.3 Aphria, Inc Medical Cannabis Product Introduction

7.7.4 Aphria, Inc Response to COVID-19 and Related Developments

7.8 MGC Pharmaceuticals Limited

7.8.1 MGC Pharmaceuticals Limited Business Overview

7.8.2 MGC Pharmaceuticals Limited Medical Cannabis Quarterly Production and Revenue, 2020

7.8.3 MGC Pharmaceuticals Limited Medical Cannabis Product Introduction

7.8.4 MGC Pharmaceuticals Limited Response to COVID-19 and Related Developments

7.9 GW Pharmaceuticals, plc

7.9.1 GW Pharmaceuticals, plc Business Overview

7.9.2 GW Pharmaceuticals, plc Medical Cannabis Quarterly Production and Revenue, 2020

7.9.3 GW Pharmaceuticals, plc Medical Cannabis Product Introduction

7.9.4 GW Pharmaceuticals, plc Response to COVID-19 and Related Developments

7.10 Medical Marijuana Inc

7.10.1 Medical Marijuana Inc Business Overview

7.10.2 Medical Marijuana Inc Medical Cannabis Quarterly Production and Revenue, 2020

7.10.3 Medical Marijuana Inc Medical Cannabis Product Introduction

7.10.4 Medical Marijuana Inc Response to COVID-19 and Related Developments

8.1 Medical Cannabis Supply Chain Analysis

8.1.1 Medical Cannabis Supply Chain Analysis

8.1.2 Covid-19 Impact on Medical Cannabis Supply Chain

8.2 Distribution Channels Analysis

8.2.1 Medical Cannabis Distribution Channels

8.2.2 Covid-19 Impact on Medical Cannabis Distribution Channels

8.2.3 Medical Cannabis Distributors

8.3 Medical Cannabis Customers

10.1 About Us

10.2 Disclaimer

List of Tables

    Table 1. Overview of the World Economic Outlook Projections

    Table 2. Summary of World Real per Capita Output (Annual percent change; in international currency at purchasing power parity)

    Table 3. European Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

    Table 4. Asian and Pacific Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

    Table 5. Western Hemisphere Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

    Table 6. Middle Eastern and Central Asian Economies: Real GDP, Consumer Prices, Current Account Balance, and Unemployment (Annual percent change, unless noted otherwise)

    Table 7. Covid-19 Impact: Global Major Government Policy

    Table 8. The Covid-19 Impact on Medical Cannabis Assessment

    Table 9. COVID-19 Impact: Medical Cannabis Market Trends

    Table 10. COVID-19 Impact Global Medical Cannabis Market Size

    Table 11. Global Medical Cannabis Market Size Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (MT)

    Table 12. Global Medical Cannabis Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026, (USD/MT)

    Table 13. Global Medical Cannabis Quarterly Market Size, 2020 (US$ Million) & (MT)

    Table 14. Global Medical Cannabis Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (US$ Million)

    Table 15. Global Medical Cannabis Market Size, Pre-COVID-19 and Post- COVID-19 Quarterly Comparison, 2020-2021 (MT)

    Table 16. Global Medical Cannabis Market Growth Drivers

    Table 17. Global Medical Cannabis Market Restraints

    Table 18. Global Medical Cannabis Market Opportunities

    Table 19. Global Medical Cannabis Market Challenges

    Table 20. Key Manufacturers Medical Cannabis Quarterly Revenue, 2019 VS 2020 (US$ Million)

    Table 21. Top Manufacturers, Medical Cannabis Market Size, 2019 (MT) & (US$ Million)

    Table 22. Medical Cannabis Factory Price by Manufacturers 2020 (USD/MT)

    Table 23. Location of Key Manufacturers Medical Cannabis Manufacturing Plants

    Table 24. Key Manufacturers Medical Cannabis Market Served

    Table 25. Date of Key Manufacturers Enter into Medical Cannabis Market

    Table 26. Key Manufacturers Medical Cannabis Product Type

    Table 27. Mergers & Acquisitions, Expansion Plans

    Table 28. Global Medical Cannabis Market Size by Type, 2020, (US$ Million)

    Table 29. Global Medical Cannabis Market Size by Type, 2020 (MT)

    Table 30. Global Medical Cannabis Price: by Type, 2020-2021 (USD/MT)

    Table 31. Global Medical Cannabis Market Size by Application: 2020-2021 (US$ Million)

    Table 32. Global Medical Cannabis Market Size by Application, 2020-2021 (MT)

    Table 33. Global Medical Cannabis Price: by Application, 2020-2021 (USD/MT)

    Table 34. Global Medical Cannabis Market Size by Region, 2019-2021 (US$ Million)

    Table 35. Global Medical Cannabis Market Size by Region, 2019-2021 (MT)

    Table 36. By Country, North America Medical Cannabis Market Size, 2019-2021 (US$ Million)

    Table 37. By Country, North America Medical Cannabis Market Size, 2019-2021 (MT)

    Table 38. US Medical Cannabis Market Size, 2019-2021 (US$ Million) & (MT)

    Table 39. Canada Medical Cannabis Market Size, 2019-2021 (US$ Million) & (MT)

    Table 40. Macroeconomic Indicators of Europe (Germany, France, UK and Italy)

    Table 41. By Country, Europe Medical Cannabis Market Size, 2019-2021 (US$ Million)

    Table 42. By Country, Europe Medical Cannabis Market Size, 2019-2021 (MT)

    Table 43. Germany Medical Cannabis Market Size, 2019-2021 (US$ Million) & (MT)

    Table 44. France Medical Cannabis Market Size, 2019-2021 (US$ Million) & (MT)

    Table 45. UK Medical Cannabis Market Size, 2019-2021 (US$ Million) & (MT)

    Table 46. Italy Medical Cannabis Market Size, 2019-2021 (US$ Million) & (MT)

    Table 47. Macroeconomic Indicators of Asia-Pacific (China, Japan, South Korea, India and ASEAN)

    Table 48. By Region, Asia-Pacific Medical Cannabis Market Size, 2019-2021 (US$ Million)

    Table 49. By Region, Asia-Pacific Medical Cannabis Market Size, 2019-2021 (MT)

    Table 50. China Medical Cannabis Market Size, 2019-2021 (US$ Million) & (MT)

    Table 51. Japan Medical Cannabis Market Size, 2019-2021 (US$ Million) & (MT)

    Table 52. South Korea Medical Cannabis Market Size, 2019-2021 (US$ Million) & (MT)

    Table 53. India Medical Cannabis Market Size, 2019-2021 (US$ Million) & (MT)

    Table 54. ASEAN Medical Cannabis Market Size, 2019-2021 (US$ Million) & (MT)

    Table 55. Latin America Medical Cannabis Market Size, 2019-2021 (US$ Million) & (MT)

    Table 56. Middle East and Africa Medical Cannabis Market Size, 2019-2021 (US$ Million) & (MT)

    Table 57. BOL Pharma Business Overview

    Table 58. BOL Pharma Medical Cannabis Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 59. BOL Pharma Medical Cannabis Product

    Table 60. BOL Pharma Response to COVID-19 and Related Developments

    Table 61. Tilray Business Overview

    Table 62. Tilray Medical Cannabis Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 63. Tilray Medical Cannabis Product

    Table 64. Tilray Response to COVID-19 and Related Developments

    Table 65. Medreleaf Corporation Business Overview

    Table 66. Medreleaf Corporation Medical Cannabis Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 67. Medreleaf Corporation Medical Cannabis Product

    Table 68. Medreleaf Corporation Response to COVID-19 and Related Developments

    Table 69. Aurora Cannabis, Inc Business Overview

    Table 70. Aurora Cannabis, Inc Medical Cannabis Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 71. Aurora Cannabis, Inc Medical Cannabis Product

    Table 72. Aurora Cannabis, Inc Response to COVID-19 and Related Developments

    Table 73. Canopy Growth Corporation Business Overview

    Table 74. Canopy Growth Corporation Medical Cannabis Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 75. Canopy Growth Corporation Medical Cannabis Product

    Table 76. Canopy Growth Corporation Response to COVID-19 and Related Developments

    Table 77. Insys Therapeutics, Inc Business Overview

    Table 78. Insys Therapeutics, Inc Medical Cannabis Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 79. Insys Therapeutics, Inc Medical Cannabis Product

    Table 80. Insys Therapeutics, Inc Response to COVID-19 and Related Developments

    Table 81. Aphria, Inc Business Overview

    Table 82. Aphria, Inc Medical Cannabis Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 83. Aphria, Inc Medical Cannabis Product

    Table 84. Aphria, Inc Response to COVID-19 and Related Developments

    Table 85. MGC Pharmaceuticals Limited Business Overview

    Table 86. MGC Pharmaceuticals Limited Medical Cannabis Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 87. MGC Pharmaceuticals Limited Medical Cannabis Product

    Table 88. MGC Pharmaceuticals Limited Response to COVID-19 and Related Developments

    Table 89. GW Pharmaceuticals, plc Business Overview

    Table 90. GW Pharmaceuticals, plc Medical Cannabis Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 91. GW Pharmaceuticals, plc Medical Cannabis Product

    Table 92. GW Pharmaceuticals, plc Response to COVID-19 and Related Developments

    Table 93. Medical Marijuana Inc Business Overview

    Table 94. Medical Marijuana Inc Medical Cannabis Production (MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin, (Q1, Q2, Q3, Q4) Quarter 2020

    Table 95. Medical Marijuana Inc Medical Cannabis Product

    Table 96. Medical Marijuana Inc Response to COVID-19 and Related Developments

    Table 97. Medical Cannabis Distributors List

    Table 98. Medical Cannabis Customers List

    Table 99. Covid-19 Impact on Medical Cannabis Customers

List of Figures

    Figure 1. Medical Cannabis Product Picture

    Figure 2. Medical Cannabis Market Segmentation

    Figure 3. Research Objectives

    Figure 4. Research Process

    Figure 5. Data Triangulation

    Figure 6. Research Approach

    Figure 7. Commodity Prices-Metals Price Indices

    Figure 8. Commodity Prices- Precious Metal Price Indices

    Figure 9. Commodity Prices- Agricultural Raw Material Price Indices

    Figure 10. Commodity Prices- Food and Beverage Price Indices

    Figure 11. Commodity Prices- Fertilizer Price Indices

    Figure 12. Commodity Prices- Energy Price Indices

    Figure 13. G20+: Economic Policy Responses to COVID-19

    Figure 14. Global Medical Cannabis Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026 (US$ Million)

    Figure 15. Global Medical Cannabis Market Size, Pre-COVID-19 and Post- COVID-19, Year-over-Year Growth Rate, 2015-2026 (%)

    Figure 16. Global Medical Cannabis Market Size, Quarterly Growth, 2020-2021 (%)

    Figure 17. Global Medical Cannabis Market Size, Market Share by Type, 2019 VS 2020 (%)

    Figure 18. Global Medical Cannabis Market Size, Market Share by Application, 2019 VS 2020 (%)

    Figure 19. Global Medical Cannabis Market Size Market Share by Region, 2019 VS 2020 (%)

    Figure 20. United States Composite PMI and GDP

    Figure 21. Eurozone Composite PMI and GDP

    Figure 22. Eurozone Core v. Periphery PMI Output Indices

    Figure 23. Core v. Periphery PMI Employment Indices

    Figure 24. UK Composite PMI and GDP

    Figure 25. Caixin China Composite Output Index

    Figure 26. Caixin China General Services Business Activity Index

    Figure 27. Japan Composite Output Index

    Figure 28. South Korea Manufacturing PMI

    Figure 29. India Composite Output Index

    Figure 30. ASEAN Manufacturing PMI

    Figure 31. By Region, Asia-Pacific Medical Cannabis Market Size Market Share, 2019-2021